An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A. Soucy, Steven Langston, Peter G. Smith et al.|Nature|2009Cited by 2k
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphomaMichael A. Milhollen, Peter G. Smith, Tary Traore et al.|Blood|2010Cited by 323
Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924Amir A. Jazaeri, Anindya Dutta, Michael A. Milhollen et al.|Molecular Cancer Therapeutics|2013Cited by 74
Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cellsScott Best, Alexey V. Danilov, Cody Paiva et al.|Blood Advances|2019Cited by 55
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cellsScott Best, Alexey V. Danilov, Vi Lam et al.|Leukemia|2020Cited by 38